Providing Access to Patent Information to Improve Global Health Outcomes
In an effort to make it easier for global drug procurement agencies to access a basic body of patent information and make life-saving treatments available to patients in even less time, Pfizer joined 20 of the world's leading biopharmaceutical companies to develop the Patent Information Initiative for Medicines (Pat-INFORMED), a public-private partnership between the World Intellectual Property Organization (WIPO), the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and research-based companies.
As of today, information on more than 18,000 patents has been uploaded to the database for the therapeutic areas currently in scope—with Pfizer contributing information on approximately 2,500 patents for 31 products.
Ian Read: Contributions to Improving Human Health
Albert Bourla: Breakthroughs that Change Patients' Lives
Ushering in a New Era of Pfizer R&D Productivity
Advancing Our Leading JAK Science
Overcoming Therapy-Resistant Disease
Tackling Respiratory Syncytial Virus (RSV) Through Breakthrough Science and Technology
Catalyzing Innovations in Global Health
Contributing to the UN Sustainable Development Goals
Supporting Digital Health Start-Ups
Improving the Health of Women and Their Families